A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation

Journal of the American College of Cardiology

Volumn 44, Issue 12, 2004, Pages 2355-2361

  Roy, Denis ^a   Rowe, Brian H ^b   Stiell, Ian G ^c   Coutu, Benoit ^d   Ip, John H ^e   Phaneuf, Denis ^f   Lee, Jacques ^g   Vidaillet, Humberto ^h   Dickinson, Garth ^c   Grant, Sheila ⁱ   Ezrin, Alan M ⁱ   Beatch, Gregory N ⁱ  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d NOTRE DAME HOSPITAL   (Canada)

^e Cardiovascular Institute   (United States)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h MARSHFIELD CLINIC   (United States)

ⁱ Vancouver   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; RSD 1235;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CANADA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; INFECTION; LUNG EDEMA; MALE; MULTICENTER STUDY; NAUSEA; NEUROLOGIC DISEASE; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINUS BRADYCARDIA; SINUS RHYTHM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 10644250949     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.09.021     Document Type: Article

References (25)

1. M.C.E.F. Wijffels, C.J.H.J. Kirchhof, R. Dorland Atrial fibrillation begets atrial fibrillation Circulation 92 1995 1954 1968
2. The Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation: clinical features of patients at risk Ann Intern Med 116 1992 1 5
3. G. Nichol, F. McAlister, A. Laupacis Meta-analysis of randomized controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation Heart 87 2002 535 543
4. P.E. Fenster, K.A. Comess, R. Marsh Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion Am Heart J 106 1983 501 504
5. S.W. Halpern, G. Ellrodt, B.N. Singh Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm Br Heart J 44 1980 589 595
6. A. Madrid, C. Moro, E. Marin-Huerta Comparison of flecainide and procainamide in cardioversion of atrial fibrillation Eur Heart J 14 1993 1127 1131
7. K.A. Boahene, G.J. Klein, R. Yee Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone J Am Coll Cardiol 16 1990 1408 1414
8. B. Olshansky, K. Okumara, P.G. Hess Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm J Am Coll Cardiol 11 1988 359 364
9. M.J. Suttorp, J.H. Kingma, E.R. Jessurun The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm J Am Coll Cardiol 16 1990 1722 1727
10. J.A. Vita, P.L. Friedman, C. Cantillon Efficacy of intravenous propafenone for the acute management of atrial fibrillation Am J Cardiol 63 1989 1275 1278
11. L. Bianconi, R. Boccadamo, A. Pappalardo Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset Am J Cardiol 64 1989 335 338
12. M.J. Suttorp, J.H. Kingma, L. Lie-A-Huen Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm Am J Cardiol 63 1989 693 696
13. A. Borgeat, J.J. Goy, R. Maendly Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm Am J Cardiol 58 1986 496 498
14. K.J. Hellestrand Intravenous flecainide for supraventricular tachycardias Am J Cardiol 62 1988 16D 22D
15. R. Faniel, P.H. Schoenfeld Efficacy of IV amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients Eur Heart J 4 1983 180 185
16. B. Strasberg, A. Arditti, S. Sclarovsky Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response Int J Cardiol 7 1985 47 58
17. K.D. Donovan, B.M. Power, B.E. Hockings Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation Am J Cardiol 75 1995 693 697
18. L. Bianconi, A. Castro, M. Dinelli., for the Italian Intravenous Dofetilide Study Group Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter Eur Heart J 21 2000 1265 1273
19. R.J. Sung, H.L. Tan, L. Karagounis Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study Am Heart J 129 1995 739 748
20. K.A. Ellenbogen, B.S. Stambler, M.A. Wood Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and flutter: a dose response study J Am Coll Cardiol 28 1996 130 136
21. M.K. Das, K. Cheriparambil, A. Bedi Cardioversion of atrial fibrillation with ibutilide: when is it most effective? Clin Cardiol 25 2002 411 415
22. G.N. Beatch, K. Shinagawa, B. Johnson RSD1235 selectively prolongs atrial refractoriness and terminates AF in dogs with electrically remodeled atria (abstr) Pacing Clin Electrophysiol 25 2002 698
23. G.N. Beatch, S.-P. Lin, J.C. Hesketh Electrophysiological mechanism of RSD1235, a new atrial fibrillation converting drug (abstr) Circulation 108 Suppl IV 2003 IV85.
24. A.M. Ezrin, S.M. Grant, G. Bell A dose-ranging study of RSD1235, a novel antiarrhythmic agent, in healthy volunteers (abstr) Pharmacologist 44 Suppl 1 2002 A15
25. V. Fuster, L.E. Ryden, R.W. Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation Circulation 104 2001 2118 2150